Haemostasis Registry

The Haemostasis Registry was established in February 2005 at the Department of Epidemiology and Preventive medicine. The purpose of this registry is to gain information on safety, efficacy and appropriateness of use and dosages of recombinant activated factor VII (rFVIIa, NovoSeven) where it is used for non-haemophiliac patients. Establishment of a register will provide valuable observational data including efficacy, adverse events, effective dosage and cost-effectiveness. This data will be of substantial value in the development of prospective trials. The registry is supported by an educational grant from Novo Nordisk.

Project Details (linked file)

Contact us

Steering Committee

Professor James Isbister (Chair)
Professor Peter Cameron
Professor John McNeil
Professor Hatem Salem
Dr Scott Dunkley 
Ms Wendy Thomas
Dr Gary Jankelowitz
Dr Louise Phillips
Mr Andrew Hannaford

Investigators Workshop May 2009

Web Data Entry

Data Forms

Data Dictionary

Volume Audit Worksheet

Is my hospital contributing?

Enrolling your hospital

Workshop Presentations May 2008

Newsletters